ChartRow logo
Data provided bySource: Twelve Data
PeersTEMWDAYBTSGABNBCRMTEAM
Share this page

VEEV — Veeva Systems Inc. price, chart and key statistics

Technical analysis2
Overlay lines0
Addendum charts0
Data provided bySource: Twelve Data
What would $1,000 invested in VEEV be worth today? →
VEEV returns: By year · By month · By week · Trailing

Price data

Price
$301.53
YTD price return
+35.08%
YTD total return
+35.08%
Next earnings
Nov 19, 2026
Market cap
48.8B
Enterprise value
47.2B
Shares outstanding
161.9M
52W low
$148.05
52W high
$325.99
From 52W high
-7.50%
From 52W low
+103.67%
52W range
86%$148–$326
Beta
0.92

Volume

Rel volume
0.51×
30D volume
1.4M
30D $ vol
441.1M

Insider trading

Insider net 1W
none
Insider net 1M
none
Insider net 3M
−$6.2M
Insider net 1Y
−$16.8M

Form 4 transactions by trade date, as filed; latest on file 2026-10-14.

Fundamentals

Sales (ttm)
3.5B
Sales/share
$21.36
EPS (ttm)
$6.11
FCF (ttm)
1.6B
FCF/share
$10.12
Book value/share
$45.90
Net margin
29.34%
ROE
13.66%
ROA
11.20%
Current ratio
5.46

Growth (CAGR, ttm) · 10Y

Sales
+16.52%+15.70%+15.76%+22.03%
Net income
+25.31%+23.39%+19.06%+34.21%
FCF
+23.41%+19.72%+16.93%+28.43%
Shares
-1.22%-0.28%-0.11%+0.96%

Per-share growth (CAGR, ttm) · 10Y

EPS
+25.54%+22.59%+18.46%+32.38%
Sales/share
+17.96%+16.03%+15.89%+20.87%
FCF/share
+24.94%+20.06%+17.06%+27.21%
Book value/share
+13.34%+21.75%+23.32%+28.16%
Price
+3.37%+21.95%-1.04%+22.49%
Total return
+3.37%+21.95%-1.04%+22.49%

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)
49.3×
P/OI (ttm)
47.2×
Fwd P/E
29.4×
P/S (ttm)
14.1×
P/B (mrq)
6.6×
P/FCF (ttm)
29.8×
EV/EBITDA (fy)
43.9×
EV/Sales (ttm)
13.6×
FCF yield (ttm)
3.36%
Buyback yield (realized, 1y)
1.22%
Shareholder yield (realized, 1y)
1.22%
Buyback yield (cash, ttm)
1.32%
Shareholder yield (cash, ttm)
1.32%

Vs own 10Y history

P/E
10th
P/OI
10th
P/S
38th
P/B
17th
P/FCF
12th

Bar = where today’s multiple sits in VEEV’s own 10-year range:near a decade-low (cheap)→mid-range→near a decade-high (rich).

Performance · price returntotal return · as of 2026-11-13#

Data provided bySource: Twelve Data
1D
-0.29%
5D
-0.72%
1M
-0.03%
3M
+19.35%
YTD
+35.08%
1Y
+3.37%
5Y
-5.08%
1D
-0.29%
5D
-0.72%
1M
-0.03%
3M
+19.35%
YTD
+35.08%
1Y
+3.37%
5Y
-5.08%

Fundamentals#

Revenue

5Y CAGR +16.9%10Y CAGR +22.8%YoY +17.6%
$3.5B TTM$928M Q2 '27
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26TTM
Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27Q2 '27

Operating income

5Y CAGR +19.4%10Y CAGR +27.8%YoY +40.4%
$1B TTM$275M Q2 '27
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26TTM
Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27Q2 '27

EPS (diluted)

5Y CAGR +18.2%10Y CAGR +30.5%YoY +39.5%
$6.11 TTM$1.66 Q2 '27
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26TTM
Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27Q2 '27

Free cash flow

5Y CAGR +20.6%10Y CAGR +37.2%YoY −0.6%
$1.6B TTM$230.7M Q2 '27
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26TTM

TTM: operating cash flow $1.7B, capex −$26.7M

Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27Q2 '27

Q2 2027: operating cash flow $238.7M, capex −$8M

Shares (diluted)

5Y +3.9%10Y +15.2%YoY −1.6%
166M TTM165.1M Q2 '27
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26TTM
Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27Q2 '27

Net income

5Y CAGR +19.1%10Y CAGR +32.5%YoY +36.5%
$1B TTM$273.4M Q2 '27
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25FY26TTM
Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26Q4 '26Q1 '27Q2 '27
Full VEEV financials →

Veeva Systems Inc. is a cloud software company that provides industry-specific solutions for the global life sciences sector. Veeva Systems Inc. offers applications, data, and consulting services designed to support pharmaceutical, biotechnology, and medical device companies across research and development, quality, and commercial operations. Its product portfolio includes platforms for clinical, regulatory, quality, and field activities, along with customer relationship management, content management, analytics, and data services tailored to life sciences workflows. The company also delivers cloud-based tools that help organizations manage complex processes from drug development through commercialization. Veeva Systems Inc. plays a central role in the life sciences technology market by combining software and data in a specialized industry cloud built for highly regulated environments. Founded in 2007 and headquartered in Pleasanton, California, the company focuses on serving customers that need compliant, scalable digital systems for critical business functions.

Pleasanton, CA·7,928 employees·Health Information Services·veeva.com·As of Oct 28, 2026

Recent filings#

All filings and insider trades →

ETFs holding VEEV#

34 of the 193 ETFs ChartRow carries live hold VEEV. The 8 largest positions, by the weight each fund filed in its latest SEC N-PORT report (Jun 26 to Aug 26).

FundNameFiled weight
VHTVanguard Health Care ETF0.6%
COWZPacer US Cash Cows 100 ETF0.6%
VOTVanguard Mid-Cap Growth ETF0.6%
XLVHealth Care Select Sector SPDR Fund0.5%
IWSiShares Russell Mid-Cap Value ETF0.3%
VOVanguard Mid-Cap ETF0.3%
RSPInvesco S&P 500 Equal Weight ETF0.2%
IWRiShares Russell Midcap ETF0.2%
TickerName1M1D
LLYEli Lilly and Company+23.75%+1.14%
JNJJohnson & Johnson+14.94%+0.79%
ABBVAbbVie Inc.+7.53%+0.20%
UNHUnitedHealth Group Incorporated Common Stock (DE)+7.86%+0.58%
MRKMerck & Co. Inc.+4.07%+0.55%
NVSNovartis AG+12.70%+0.16%
TMOThermo Fisher Scientific Inc.+5.61%+0.11%
AMGNAmgen Inc.+12.80%-0.30%